Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human lecithin cholesterol acyltransferase

EU orphan designation number: EU/3/12/1051   
Active ingredient: Recombinant human lecithin cholesterol acyltransferase
Indication: Treatment of lecithin cholesterol acyltransferase deficiency
Sponsor: Alphacore Pharma Limited
c/o Arnold & Porter (UK) LLP Tower 42, 25 Old Broad Street, London, EC2N 1HQ, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2012 Centralised Orphan - Designation EMA/OD/091/12 (2012)7228 of 10/10/2012